.
ResMed Inc (ASX:RMD) earned $73 million in the fourth quarter ended June 30.
The maker of devices for sleep-disordered breathing, ResMed says it had record revenue for the quarter of $414.6 million - 11 per cent more than the same quarter last year.
For the year ended June 30, 2013, net income was $307.1 million, an increase of 21 percent over the previous year.
The company says fourth quarter net income was reduced by a $17.7 million charge for settling litigation with the University of Sydney.
CEO Mick Farrell says the quarterly dividend has increased 47 per cent to 25 cents per share.
News: ResMed earns $73M in quarter
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$38.58 |
Change
0.470(1.23%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $38.50 | $38.59 | $38.25 | $10.11M | 263.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 947 | $38.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $38.59 | 6 | 1 |
View Market Depth
| Last trade - 10.40am 28/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
